2011-04-18 00:00:00,Biogen Idec and Elan plc Announce CHMP Recommendation Updating TYSABRI Labeling with Virus Antibody Status as Third Factor to Further Stratify Risk of PML
2012-10-12 00:00:00,Biogen Idec Inc Announces New Data From Phase 3 Studies For Oral In Multiple Sclerosis
